I have pain, swelling, and stiffness in the right hand proximal interphalangeal (PIP) joint and now moderate pain in multiple joints; what is the likely diagnosis and what evaluation and treatment should I pursue?

Urgent Rheumatology Referral Required

You need to see a rheumatologist within 6 weeks of symptom onset—this presentation of PIP joint pain with swelling, stiffness, and progression to multiple joints strongly suggests inflammatory arthritis (likely rheumatoid arthritis), and early treatment with disease-modifying drugs is critical to prevent permanent joint damage and disability. 1

Why This Matters for Your Long-Term Outcome

The pattern you describe—starting in one PIP joint and spreading to multiple joints with swelling and stiffness—is a classic presentation of inflammatory arthritis. The window for preventing irreversible joint damage is narrow: treatment should ideally begin within 3 months of symptom onset. 1 Delays lead to worse outcomes including permanent joint destruction, loss of hand function, and reduced quality of life.

What Your Rheumatologist Will Do

Clinical Evaluation

• Physical examination is the primary method for confirming arthritis, which can be supplemented with ultrasonography if needed 1
• Assessment of which specific joints are swollen and tender
• Evaluation of morning stiffness duration (prolonged morning stiffness is characteristic of inflammatory arthritis) 2

Laboratory Testing

Your rheumatologist will order:

• Inflammatory markers: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) 2, 1
• Rheumatoid factor and anti-citrullinated protein antibodies (ACPA) to assess risk of persistent/erosive disease 1
• These tests help determine prognosis and guide treatment intensity

Imaging

• Baseline imaging to assess for early joint damage
• Ultrasonography can confirm inflammation when clinical examination is uncertain 1

Treatment You Should Expect

Immediate Management (While Awaiting Definitive Diagnosis)

If you're at risk for persistent arthritis based on multiple joint involvement, you should start disease-modifying antirheumatic drugs (DMARDs) even before meeting full classification criteria for a specific rheumatologic disease. 1

Methotrexate is the anchor drug and should be part of your first treatment unless you have contraindications. 1 This is the gold standard first-line therapy because it:

• Slows disease progression
• Prevents joint damage
• Has decades of safety and efficacy data

Symptomatic Relief

• NSAIDs at the minimum effective dose for the shortest duration after evaluating your gastrointestinal, kidney, and cardiovascular risks 1
• Short-term glucocorticoids (less than 6 months) at the lowest necessary dose can reduce pain, swelling, and structural damage while DMARDs take effect 1
• Intra-articular steroid injections for particularly problematic joints 1

Treatment Goal

The target is clinical remission—meaning no detectable inflammatory activity, no swollen or tender joints, minimal morning stiffness, and normal inflammatory markers. 2 This requires:

• Regular monitoring every 1-3 months until remission is achieved 1
• Adjusting treatment if you don't respond adequately
• Using composite disease activity scores to track progress 2, 1

Critical Pitfalls to Avoid

1. Delaying rheumatology referral: Every week of delay increases risk of irreversible joint damage
2. Assuming this is just a "sprain" or "overuse": While PIP joint sprains can cause prolonged swelling 3, the progression to multiple joints with stiffness points to systemic inflammatory disease
3. Waiting for "definitive diagnosis": Treatment should start based on risk factors for persistent disease, not classification criteria 1
4. Prolonged immobilization or inadequate treatment: This leads to persistent swelling, instability, and limited range of motion that becomes difficult to reverse 4

Additional Management Components

• Smoking cessation (if applicable—smoking worsens rheumatoid arthritis)
• Physical therapy and occupational therapy as adjuncts to medication 1
• Weight management and vaccination status review 1
• Regular monitoring for treatment side effects and comorbidities 1

Bottom Line

Your symptom pattern demands urgent evaluation. The difference between early aggressive treatment and delayed treatment is measured in permanent joint function and quality of life. Contact a rheumatologist immediately—do not wait for symptoms to worsen or for your primary care provider to "rule out" other conditions first.